https://pharmastrategies.co.za/wp-content/uploads/2019/12/Pharma-Strategies-Website-Logo-300x138.png00imberje1https://pharmastrategies.co.za/wp-content/uploads/2019/12/Pharma-Strategies-Website-Logo-300x138.pngimberje12024-12-02 12:05:122024-12-02 12:05:12Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington’s disease
